Compugen Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on July 9, 2012, reports the results of Compugen Ltd.'s 2012 Annual General Meeting of Shareholders held on July 3, 2012. The company is a foreign private issuer based in Tel-Aviv, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes.
Material Changes and Voting Results
Of the 35,990,311 ordinary shares eligible to vote, a quorum of 10,574,272 shares (29.38%) was present. The following actions were approved:
- Board Re-elections: Shareholders re-elected Prof. Ruth Arnon, Mr. Martin Gerstel, Mr. Dov Hershberg, and Mr. Alex Kotzer to the Board of Directors for one-year terms.
- Accounting Firm: Kost Forer Gabbay & Kasierer (Ernst & Young Global) was reappointed as the independent registered public accounting firm for the fiscal year ending December 31, 2012.
- Executive Compensation: Shareholders approved granting Mr. Martin Gerstel, Chairman of the Board, options to purchase 62,500 Ordinary Shares at an exercise price of $4.01 per share, vesting in calendar year 2014.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the final composition of the Board of Directors, which now includes Prof. Yair Aharonowitz, Prof. Ruth Arnon, Mr. Martin Gerstel, Mr. Dov Hershberg, Mr. Alex Kotzer, Mr. Arie Ovadia, and Prof. Joshua Shemer.
- Confirm the terms of the stock option grant to Mr. Martin Gerstel (62,500 shares at $4.01 exercise price).
- Review the Proxy Statement filed on May 22, 2012, for detailed background on the proposals.